The new way to screen for prostate cancer.
WHAT OUR AI DOES
*Measuring the actual 3D segmentation volume instead of an ellipsoid approximation.
ezra ai technology
Powered by Plexo — our full-featured, cloud-based, FDA-cleared PACS
The Ezra Picture Archiving and Communications System (PACS) is tightly integrated with the Ezra Prostate AI. It's packed with features and accessible from your browser.
Ezra Prostate AI
Embraced by expert radiologists
Oguz Akin, M.D.
Professor of Radiology
Memorial Sloan Kettering Cancer Center
“Artificial Intelligence will, without a doubt, revolutionize radiology. Ezra’s Prostate AI can help radiologists become faster, more consistent, and, in the future, exponentially increase accuracy.”
Lawrence Tanenbaum, M.D., FACR
Director of MRI, CT and Advanced Imaging
“Ezra is at the forefront of MRI-based cancer screening, and the company’s 510k FDA clearance for its Prostate interpretation AI is further validation of its innovation capabilities.”
Robert Princenthal, M.D.
Medical co-director for RadNet’s Prostate MRI Program
RadNet Southern California
“Multiparametric prostate MRI is the future of prostate cancer screening. Ezra is leading the way in the Prostate MRI space by being the first company in the U.S. to obtain 510k FDA clearance for its Prostate AI technology.”
John Melnick, M.D.
Lenox Hill Radiology
“Prostate MRI is the best way to screen men for prostate cancer. Ezra’s FDA-cleared AI-based prostate and lesion segmentation tool is a step forward towards making MRI-based prostate cancer screening a reality.”
Jasnit Makkar, M.D.
Assistant Professor of Radiology
Columbia University Medical Center
“Artificial Intelligence will reinvent radiology. Ezra’s FDA-cleared state-of-the-art Prostate AI technology will help radiologists all over the U.S. deliver better clinical care to their patients.”